Cleared Traditional

K140638 - PROPELLER SYSTEM - MODEL 2

K140638 is an FDA 510(k) clearance for PROPELLER SYSTEM - MODEL 2, manufactured by Reciprocal Labs Corporation. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 51-day FDA review.

K140638 · Reciprocal Labs Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2014
Decision
51d
Days
Class 2
Risk

K140638 is an FDA 510(k) clearance for the PROPELLER SYSTEM - MODEL 2. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Reciprocal Labs Corporation (Madison, US). The FDA issued a Cleared decision on May 2, 2014 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Reciprocal Labs Corporation devices

FDA 510(k) Submission Details - K140638

510(k) Number K140638 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2014
Decision Date May 02, 2014
Days to Decision 51 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 140d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 349
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K140638.
RESPICONNECT ADAPTER
K140919 · Trudell Medical Int'L · Aug 2014
BREEZE NEBULIZER (NBR-10X)
K133105 · Digio2 International Co., Ltd. · Jun 2014
ULTRASONIC MESH NEBULIZER
K140211 · Foshan Gaunying Electronics Co., Ltd. · May 2014
SMARTTOUCH
K133951 · Nexus6, Ltd. · Apr 2014
ULTRASONIC MESH NEBULIZER
K132247 · Foshan Gaunying Electronics Co., Ltd. · Jan 2014
COMPRESSOR NEBULIZER MODEL MCN-S600XX
K123030 · Dongguan Aidisy Machinery & Electronic Equipment C · Dec 2013